{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:34:19Z","timestamp":1761057259218,"version":"3.41.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,7,1]],"date-time":"2001-07-01T00:00:00Z","timestamp":993945600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2001,7]]},"DOI":"10.1023\/a:1012754514127","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T14:27:29Z","timestamp":1040653649000},"page":"309-314","source":"Crossref","is-referenced-by-count":8,"title":["ACE-Inhibition plus Mineralocorticoid Antagonism versus ACE-inhibition alone in Patients with Anterior Myocardial Infarction"],"prefix":"10.1007","volume":"15","author":[{"given":"Pietro","family":"Di Pasquale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Cannizzaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Scandurra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Giubilato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiano","family":"Scalzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Paterna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"382271_CR1","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","volume":"83","author":"KT Weber","year":"1991","unstructured":"Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium fibrosis and renin angiotensin aldosterone system. Circulation 1991; 83: 1849-1865.","journal-title":"Circulation"},{"key":"382271_CR2","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/0002-9149(93)90238-8","volume":"71","author":"KT Weber","year":"1993","unstructured":"Weber KT, Villarreal D. Aldosterone and antialdosterone therapy in congestive heart failure. Am J Cardiol 1993; 71: 3A-11A.","journal-title":"Am J Cardiol"},{"key":"382271_CR3","doi-asserted-by":"crossref","first-page":"12A","DOI":"10.1016\/0002-9149(93)90239-9","volume":"71","author":"CG Brilla","year":"1993","unstructured":"Brilla CG, Matsubara LS, Weber KT. Antifibrotic effects of spironolactone in preventing myocardial fibrosis in systemic arterial hypertension. Am J Cardiol 1993; 71: 12A-16A.","journal-title":"Am J Cardiol"},{"key":"382271_CR4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0008-6363(96)88542-7","volume":"29","author":"E Van Belle","year":"1995","unstructured":"Van Belle E, Bauters C, Lablanche JM, Bertrand ME. Neointimal thickening after balloon denudation is enhanced by aldosterone and inhibited by spironolactone, an aldosterone antagonist. Cardiovasc Res 1995; 29: 27-32.","journal-title":"Cardiovasc Res"},{"key":"382271_CR5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/j.1552-4604.1993.tb03901.x","volume":"33","author":"C Borghi","year":"1993","unstructured":"Borghi C, Boschi S, Ambrosioni E, Melandri G, Branzi A, Magnani B. Evidence of partial escape of renin angiotensin aldosterone blockade in patients with acute myocardial infarction treated with ACE inhibitors. J Clin Pharmacol 1993; 33: 40-45.","journal-title":"J Clin Pharmacol"},{"key":"382271_CR6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S1071-9164(96)80009-1","volume":"2","author":"AD. Struthers","year":"1996","unstructured":"Struthers AD. Aldosterone escape during angiotensin converting enzyme inhibitor therapy in chronic heart failure. J Card Fail 1996; 2: 47-54.","journal-title":"J Card Fail"},{"key":"382271_CR7","first-page":"643","volume":"125","author":"JA Rodriguez","year":"1997","unstructured":"Rodriguez JA, Godoy I, Castro P, et al. Effects of ramipril and spironolactone on ventricular remodeling after acute myocardial infarction: Randomized and double-blind study. Rev Med Chil 1997; 125: 643-652.","journal-title":"Rev Med Chil"},{"key":"382271_CR8","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","volume":"341","author":"B Pitt","year":"1999","unstructured":"Pitt B, Zannad F, Remme WJ, et al. For the Randomized Aldactone Evaluation Study Investigators. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709-717.","journal-title":"N Engl J Med"},{"key":"382271_CR9","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","volume":"2","author":"NB Schiller","year":"1989","unstructured":"Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantification of left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2: 358-367.","journal-title":"J Am Soc Echocardiogr"},{"key":"382271_CR10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0894-7317(97)70062-2","volume":"10","author":"JK Oh","year":"1997","unstructured":"Oh JK, Appleton CP, Hatle LK, et al. The noninvasive assessment of left ventricular diastolic function with two-dimensional and doppler echocardiography. J Am Soc Echocardiogr 1997; 10: 246-70.00.","journal-title":"J Am Soc Echocardiogr"},{"key":"382271_CR11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1011119003788","volume":"15","author":"TheEPHESUS Trial","year":"2001","unstructured":"TheEPHESUS Trial: Eplerenone in patients with heart failure due to systolic dysfunction complicating acute myocardial infarction. The EPHESUS Investigators. Cardiovasc Drugs Ther 2001; 15: 79-87.","journal-title":"Cardiovasc Drugs Ther"},{"key":"382271_CR12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1677\/joe.0.0910457","volume":"91","author":"J Staessen","year":"1981","unstructured":"Staessen J, Lijnen P, Fagard R, Verschueren LJ, Amery A. Rise in plasma concentration of aldosterone during longterm angiotensin II suppression. J Endocr 1981; 91: 457-465.","journal-title":"J Endocr"},{"key":"382271_CR13","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/00005344-198211000-00014","volume":"4","author":"J Biolaz","year":"1982","unstructured":"Biolaz J, Brunner HR, Gavras I, Waeber B, Gavras H. Antihypertensive therapy with MK 421: Angiotensin II-renin relationship to evaluate efficacy of converting enzyme blockade. J Cardiovasc Pharmacol 1982; 4: 966-972.","journal-title":"J Cardiovasc Pharmacol"},{"key":"382271_CR14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF00877755","volume":"9","author":"B. Pitt","year":"1995","unstructured":"Pitt B. Escape of aldosterone production in patients with left ventricular dysfunction treated with an angiotensin converting enzyme inhibitor: implications for therapy. Cardiovasc Drugs Ther 1995; 9: 145-149.","journal-title":"Cardiovasc Drugs Ther"},{"key":"382271_CR15","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0002-9149(96)00465-1","volume":"78","author":"The RALES Investigators.","year":"1996","unstructured":"The RALES Investigators. Effectiveness of spironolactone added to an angiotensin converting enzyme inhibitor and loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study (RALES). Am J Cardiol 1996; 78: 902-907.","journal-title":"Am J Cardiol"},{"key":"382271_CR16","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","volume":"67","author":"CG Brilla","year":"1990","unstructured":"Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT. Remodeling of rat right and left ventricles in experimental hypertension. Circ Res 1990; 67: 1355-1364.","journal-title":"Circ Res"},{"key":"382271_CR17","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1053\/euhj.1998.1099","volume":"19","author":"DA Duprez","year":"1998","unstructured":"Duprez DA, De Buyzere ML, Rietzschel ER, et al. Inverse relationship betwen aldosterone and artery compliance in chronically treated heart failure patients. Eur Heart J 1998; 19: 1371-1376.","journal-title":"Eur Heart J"},{"key":"382271_CR18","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0002-9149(99)80353-1","volume":"76","author":"CS Barr","year":"1995","unstructured":"Barr CS, Lang CC, Hanson J, Arnott M, Kennedy N, Struthers AD. Effects of adding spirolactone to an angiotension-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol 1995; 76: 1259-1265.","journal-title":"Am J Cardiol"},{"key":"382271_CR19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0006-8993(93)91332-M","volume":"629","author":"SH Mellon","year":"1993","unstructured":"Mellon SH, Deschepper CF. Neurosteroid biosynthesis: Gene for adrenal for steroidogenic enzymes are expressed in the brainb. Brain Res 1993; 629: 283-292.","journal-title":"Brain Res"},{"key":"382271_CR20","doi-asserted-by":"crossref","first-page":"24316","DOI":"10.1016\/S0021-9258(19)51084-5","volume":"269","author":"H Hatakeyama","year":"1994","unstructured":"Hatakeyama H, Miyamori I, Fujuta T, Takeda Y, Takeda R, Yamamoto H. Vascular aldosterone. Biosynthesis and a link to angiotensin II induced hypertrophy of vascular smooth muscle cells. t\nJ Biol Chem 1994; 269: 24316-24320.","journal-title":"J Biol Chem"},{"key":"382271_CR21","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1677\/joe.0.0430315","volume":"43","author":"JR Knox","year":"1969","unstructured":"Knox JR, Lockett MF. Similarity bettween a substance produced by the heart in vitro and the 18-monoacetyl derivative of D-aldosterone. J Endocr 1969; 43: 315-316.","journal-title":"J Endocr"},{"key":"382271_CR22","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1074\/jbc.273.9.4883","volume":"273","author":"JS Silvestre","year":"1998","unstructured":"Silvestre JS, Robert V, Heymes C, et al. Myocardial production of aldosterone and corticosterone in rat. Physiological regulation. J Biol Chem 1998; 273: 4883-4891","journal-title":"J Biol Chem"},{"key":"382271_CR23","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1006\/jmcc.1996.0072","volume":"28","author":"SH Slight","year":"1996","unstructured":"Slight SH, Ganjam VK, Gomez-Sanchez CE, Zhou MY, Weber KT. High affinity NAD+ dependent 11beta-hydroxysteroid dehydrogenase in the human heart. J Mol Cell Cardiol 1996; 28: 781-787.","journal-title":"J Mol Cell Cardiol"},{"key":"382271_CR24","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1161\/01.RES.81.5.857","volume":"81","author":"M Volpe","year":"1997","unstructured":"Volpe M, Gigante B, Enea I, et al. Role of tissue renin in the regulation of aldosterone biosynthesis in the adrenal cortex of the nephrectomized rats. Circ Res 1997; 81: 857-864.","journal-title":"Circ Res"},{"key":"382271_CR25","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.99.20.2694","volume":"99","author":"JS Sivestre","year":"1999","unstructured":"Sivestre JS, Heymes C, Oubenaissa A, et al. Activation of cardiac aldosterone production in rat myocardial infarction. Circulation 1999; 99: 2694-2701.","journal-title":"Circulation"},{"key":"382271_CR26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM199909023411009","volume":"341","author":"KT. Weber","year":"1999","unstructured":"Weber KT. Aldosterone and spironolactone in heart failure. N Engl J Med 1999; 341: 753-755.","journal-title":"N Engl J Med"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1012754514127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1012754514127\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1012754514127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:18:45Z","timestamp":1751051925000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1012754514127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,7]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,7]]}},"alternative-id":["382271"],"URL":"https:\/\/doi.org\/10.1023\/a:1012754514127","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"type":"print","value":"0920-3206"},{"type":"electronic","value":"1573-7241"}],"subject":[],"published":{"date-parts":[[2001,7]]}}}